TANFAC INDUSTRIES LTD.-$

Tanfac Industries Ltd has received a Monitoring Agency Report from CRISIL Rating Limited for the quarter ended June 30, 2026, concerning the utilization of proceeds from its Qualified Institutional Placement (QIP). The report, issued on August 10, 2026, confirms that there has been no deviation from the objects disclosed in the Offer Document. The QIP, which took place from June 23 to June 25, 2026, raised gross proceeds of ₹24,999.97 lakhs (net proceeds of ₹23,567.01 lakhs). Notably, no proceeds were utilized during the reported quarter.

TANFAC Industries Ltd held its Extra-Ordinary General Meeting (EGM) on Thursday, July 30, 2026, via video conferencing. The meeting was attended by 70 members and key management personnel, including the Chairperson, Managing Director, and Independent Directors. The EGM was convened to consider and transact special business as outlined in the notice dated July 08, 2026. Key agenda items included the approval for the issue of up to 4,24,647 equity shares on a preferential basis and the appointment of Dr. D. Karthikeyan as a Nominee Director. The proceedings also covered e-voting procedures and the role of the appointed scrutinizer.

TANFAC Industries Ltd has filed its Statement of Deviation or Variation in the utilization of funds raised through Qualified Institutional Placement (QIP) for the quarter ended June 30, 2026. The company raised ₹24,999.97 Crores via QIP on June 25, 2026. The statement details the original objects for which funds were raised, including financing the project cost for establishing a refrigerant gas plant for manufacturing HIFC-32. The filing indicates that the company has completed its QIP of equity shares. The statement is submitted in XBRL mode along with financial statements.

TANFAC Industries Limited announced its unaudited financial results for Q1 FY27, reporting revenue of approximately ₹187 crore, a 6.3% year-on-year growth driven by higher capacity utilization and increased contribution from Solar Grade DHF. However, revenue saw a 3.1% sequential decline due to geopolitical disruptions in West Asia. Raw material and fuel costs were elevated, impacting Operating EBITDA. Profit After Tax (PAT) was affected by lower operating profit and deferred tax adjustments. The company highlighted the successful completion of a ₹250 crore QIP and a proposed ₹100 crore preferential issue, which will fund a ₹390 crore HFC-32 refrigerant gas project. This capital raise has made TANFAC net debt-free, positioning it for future growth and downstream expansion.

TANFAC Industries Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved the results and the limited review report. Additionally, the Board fixed the date for the 52nd Annual General Meeting (AGM) on September 23, 2026, to be held via video conferencing. The Board also recommended the appointment of M/s. Ramasamy Koteswara Rao and Co LLP as Statutory Auditors for a term of five years, subject to shareholder approval.

TANFAC Industries Ltd has announced that its Board of Directors will convene on July 24, 2026. The primary agenda item for this meeting is to consider and approve the company's Unaudited Financial Results for the quarter ending June 30, 2026. Additionally, the trading window for designated persons and connected individuals will remain closed until further notice, in accordance with SEBI regulations. The company has also made this information available on its investor website.

TANFAC Industries Limited has announced an Extra-Ordinary General Meeting (EGM) to be held on July 30, 2026, via Video Conferencing. The primary agenda is to approve the preferential issue of up to 4,24,647 equity shares. The meeting will also cover other special businesses as detailed in the notice. Remote e-voting will be open from July 27 to July 29, 2026, for members registered as of the cut-off date, July 23, 2026. The notice and explanatory statement have been sent electronically to eligible members.

TANFAC Industries Limited has announced a reduction in its proposed preferential issue size from ₹1,73,48,72,962 to ₹99,40,98,627. This adjustment is due to a revised expression of interest from promoter Anupam Rasayan India Limited. The company will now raise funds by issuing up to 4,24,647 equity shares at ₹2,341.00 per share. The funds will be raised through a private placement to identified allottees including Anupam Rasayan India Limited, Alrox Enterprises Private Limited, Vivek Jain, and Tatvam Trade. The decision was approved by the Preferential Issue Committee of the company.

TANFAC Industries Ltd has issued a clarification regarding an inadvertent error in a previous filing. The company has now submitted the correct press release detailing the successful completion of the first tranche of its fund raise through a Qualified Institutional Placement (QIP) on June 25, 2026, amounting to approximately ₹250 crore by allotting 12,58,918 equity shares. Additionally, the Board has approved a preferential issue of 7,41,082 equity shares at ₹2,341 per share, aggregating approximately ₹173.5 crore, subject to shareholder and regulatory approvals. The promoter, Anupam Rasayan India Limited, will invest ₹135 crore in this preferential issue, with other institutional investors subscribing to the balance. The total capital raised is approximately ₹423.5 crore, intended for strategic growth initiatives including expansion into the R-32 refrigerant gas segment and value-added fluorochemical products.

TANFAC Industries Limited announced its Board of Directors has approved a preferential issue of approximately ₹173.5 crore at ₹2,341 per equity share. This follows a successful Qualified Institutional Placement (QIP) of ₹250 crore. The preferential issue includes ₹135 crore from Promoter Anupam Rasayan India Limited and subscriptions from other institutional investors. The combined capital raise of ₹423.5 crore aims to support the company's growth and expansion plans, including strengthening its R-32 refrigerant gas segment, expanding its fluorochemical product portfolio, and undertaking strategic investments. This capital infusion is expected to enhance the company's financial position and reinforce investor confidence.